Disclosure Panels Details Page

Melanoma Panel - Disclosures as of 07/21/2019

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Has Attended
Mark Albertini MD Apeiron Biologics, Vienna, Austria
Bristol Myers Squibb
Merck & Co., Inc.
None None None
Christopher Barker MD Amgen Inc.
Bristol Myers Squibb
Elekta
Merck & Co., Inc.
University California San Francisco
Regeneron Pharmaceuticals, Inc. None None
Marian Birkeland PhD None None None None -
William Carson III MD None None None None -
Daniel Coit MD, FACS None None None None
Carlo Contreras MD NA NA NA NA
Gregory Daniels MD, PhD Bristol Myers Squibb
Iovance
Merck & Co., Inc.
Nektar Therapeutics
sanofi-aventis U.S. Regeneron Pharmaceuticals, Inc.
sanofi-aventis U.S.
None
Sarah DeVincenzo PharmD, BCPS None Decision Resources Group Consulting None None -
Dominick DiMaio MD None None None None
Alison Durham MD Dynavax Technologies Corporation None None None
Anita Engh PhD None None None None
Ryan Fields MD None None None None
Martin Fleming MD, FACS None None None None
Morganna Freeman DO Amgen Inc.
Bristol Myers Squibb
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Regeneron Pharmaceuticals, Inc.
None None None
Anjela Galan MD None None None None
Brian Gastman MD Cardinal Health
castle biosciences
Merck & Co., Inc.
quest imaging
quest imaging Cardinal Health
Castle Biosciences
Merck & Co., Inc.
None
Kristina Gregory MSN, RN None None None None -
Kenneth Grossmann MD, PhD None Array
Bristol Myers Squibb
Novartis Pharmaceuticals Corporation
None None
Valerie Guild MBA None None None None
Evelyn Handel PharmD, BCOP, BCPS None None None None -
Douglas Johnson MD, MSCI None Array Biopharma
Bristol Myers Squibb
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
None None
Richard Joseph MD None Bristol Myers Squibb
Merck & Co., Inc.
None None
Giorgos Karakousis MD Merck & Co., Inc. Weiss&Paarz None None
Ann Karosas RPh, BCOP None None None None -
Julie Lange MD, ScM None None None None
Miguel Materin MD None Castle Bioscience
Expert witness
Ideaya Biosciences
None None -
Nicole McMillian MS None None None None
Sameer Nath MD None None None None
Anthony Olszanski MD, RPh None Alermes
Array
EMD Serono
Iovance
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
None None
Patrick Ott MD, PhD Bristol Myers Squibb
Celldex Therapeutics
Genentech, Inc.
MedImmune Inc.
Merck & Co., Inc.
Pfizer Inc.
Genentech, Inc. None None
Sharon Park PharmD, BCOP None None None None -
Donna Powell DHSc, CMD, RT(T) None None None None -
Kumar Rao MD Castle Bioscience None None None -
Leslie Ray PharmD None None None None -
Ramesh Rengan MD, PhD None None None None -
Merrick Ross MD None Amgen Inc.
CastleBiosciences
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Provectus Pharmaceuticals
Amgen Inc.
CastleBiosciences
Merck & Co., Inc.
Provectus Pharmaceuticals
None
April Salama MD Bristol Myers Squibb
Celldex Therapeutics
Dynavax
Genentech, Inc.
Immunocore
Incyte Corporation
Merck & Co., Inc.
Array None None
Jack Skinner PhD None None None None -
Joseph Skitzki MD None None None None
Jeffrey Sosman MD None Array Pharma
Bristol Myers Squibb
Roche Laboratories, Inc.
None None
Bettyanne Sunderland BSN, OCN None None None None -
Susan Swetter MD None None None None
Kenneth Tanabe MD NIH/DCP
Phase I clinical trial of oncolytic virus
Advance Medical
American Cancer Society
Best Doctors
Cancer Experts Now
Helix12
Leidos
UpToDate
None None -
John Thompson MD Calithera
Celldex Therapeutics
AstraZeneca Pharmaceuticals LP None None
Erin Vidic None None None None -
Evan Wuthrick MD None None None None